Centre Hospitalier Universitaire D'Amiens

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis	Hemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosis	Recruiting	Phase 1 / Phase 2	2026-10-02		NCT04176198
Non-steroidal Anti-inflammatory Drugs in Pleurodesis	Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, agnosia, nervous system disorder, perceptual disorders, pleural disorder, pneumothorax, respiratory system disorder	Recruiting	Phase 2	2025-03-19		NCT06731647

Clinical trials